Search

Your search keyword '"CD133"' showing total 3,092 results

Search Constraints

Start Over You searched for: Descriptor "CD133" Remove constraint Descriptor: "CD133"
3,092 results on '"CD133"'

Search Results

1. CD133-targeted afatinib nanomicelles for enhanced lung cancer theranostics.

2. A randomized controlled study of neoadjuvant metformin with chemotherapy in nondiabetic breast cancer women: The METNEO study.

3. Immunohistochemical Expression of Adult Stem Markers in Salivary Mucoepidermoid Carcinoma with Relevance to Molecular Profiling: Any Prognostic Implications and Oncogenic Mechanisms Eked?

4. DLK1 Is Associated with Stemness Phenotype in Medullary Thyroid Carcinoma Cell Lines.

5. CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.

6. Phenotypic Biomarkers of Aqueous Extracellular Vesicles from Retinoblastoma Eyes.

7. 3D Culture Cells Technique for Exosomes Isolation of HEK293 and its Application on WiDr Cells.

8. Glioblastoma Sensitization to Therapeutic Effects by Glutamine Deprivation Depends on Cellular Phenotype and Metabolism.

9. Interconnection of CD133 Stem Cell Marker with Autophagy and Apoptosis in Colorectal Cancer.

10. Characterizing CD133 and NANOG Expression in Melanoma: Associations with Histological and Epidemiological Parameters.

11. Clinical exome analysis and targeted gene repair of the c.1354dupT variant in iPSC lines from patients with PROM1-related retinopathies exhibiting diverse phenotypes

12. CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.

13. CD133 在肿瘤免疫逃逸及诊断的研究进展.

14. Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in Glioblastoma.

15. Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine.

16. Clinical exome analysis and targeted gene repair of the c.1354dupT variant in iPSC lines from patients with PROM1-related retinopathies exhibiting diverse phenotypes.

17. Varieties of interactions of anti-CD133 aptamers with cell cultures from patient glioblastoma

18. Immunohistochemical Expression of Adult Stem Markers in Salivary Mucoepidermoid Carcinoma with Relevance to Molecular Profiling: Any Prognostic Implications and Oncogenic Mechanisms Eked?

19. Identification of placenta-specific protein 1 (PLAC-1) expression on human PC-3 cell line-derived prostate cancer stem cells compared to the tumor parental cells

20. Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit

21. Identification of placenta-specific protein 1 (PLAC-1) expression on human PC-3 cell line-derived prostate cancer stem cells compared to the tumor parental cells.

22. The Impact of Glycosylation on the Functional Activity of CD133 and the Accuracy of Its Immunodetection.

23. Targeting Endothelial Progenitor Cells Reparative Potential Via Canonical Wnt/NOX-4 Signaling Pathway in Rats Dyslipidemia: Role of Resveratrol.

24. Comparative Analysis of Primary Ovarian Cancer Cells and Established Cell Lines as a New Tool for Studies on Ovarian Cancer Cell Complexity.

25. Hyperbaric air mobilizes stem cells in humans; a new perspective on the hormetic dose curve.

26. CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma.

27. The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer.

28. Imumunohistochemical analysis of CD133 and nucleostemin in squamous cell carcinoma and adenocarcinoma.

29. Correlation analysis of cancer stem cell marker CD133 and human endogenous retrovirus (HERV)-K env in SKOV3 ovarian cancer cells.

30. Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease

31. 89Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs

32. CD133 significance in glioblastoma development: in silico and in vitro study

33. High CD133 expression in proximal tubular cells in diabetic kidney disease: good or bad?

34. Characterizing CD133 and NANOG Expression in Melanoma: Associations with Histological and Epidemiological Parameters

40. 89Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs.

41. Characteristics of Cancer Stem Cells and Their Potential Role in Endometrial Cancer.

42. Production of a Ribosome-Displayed Mouse scFv Antibody Against CD133, Analysis of Its Molecular Docking, and Molecular Dynamic Simulations of Their Interactions.

43. CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.

44. The Interaction between Collagen 1 and High Mannose Type CD133 Up‐Regulates Glutamine Transporter SLC1A5 to Promote the Tumorigenesis of Glioblastoma Stem Cells.

45. Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment.

46. The Role of Cancer Stem Cell Markers in Ovarian Cancer.

47. Heterogeneity of cancer stem cell‐related marker expression is associated with three‐dimensional structures in malignant pleural effusion produced by lung adenocarcinoma.

48. Combining microfluidic chip and low-attachment culture devices to isolate oral cancer stem cells.

49. CD133-containing microvesicles promote colorectal cancer progression by inducing tumor angiogenesis

50. Significant CircRNAs in liver cancer stem cell exosomes: mediator of malignant propagation in liver cancer?

Catalog

Books, media, physical & digital resources